Biogen (BIIB)
(Delayed Data from NSDQ)
$234.64 USD
+0.56 (0.24%)
Updated Dec 1, 2023 04:00 PM ET
After-Market: $234.61 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/21/2024
Time: -- |
12/2023 | $3.19 | -0.93% |
Earnings Summary
For their last quarter, Biogen (BIIB) reported earnings of $4.36 per share, beating the Zacks Consensus Estimate of $3.99 per share. This reflects a positive earnings surprise of 9.27%. Look out for BIIB's next earnings release expected on February 21, 2024. For the next earning release, we expect the company to report earnings of $3.19 per share, reflecting a year-over-year decrease of 21.23%.
Earnings History
Price & Consensus
Zacks News for BIIB
Prothena (PRTA) Pipeline Shows Promise in a Tough AD Market
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services